Depletion of skeletal muscle protein mainly results from enhanced protein breakdown, caused by activation of proteolytic systems such as the Ca2?-dependent and the ATP-ubiquitin-dependent ones. In the last few years, enhanced expression and bioactivity of myostatin have been reported in several pathologies characterized by marked skeletal muscle depletion. More recently, high myostatin levels have been associated with glucocorticoidinduced hypercatabolism. The search for therapeutical strategies aimed at preventing/correcting protein hypercatabolism has been directed to inhibit humoral mediators known for their pro-catabolic action, such as TNFa. The present study has been aimed to investigate the involvement of TNFa in the regulation of both myostatin expression and intracellular protein catabolism, and the possibility to interfere with such modulations by means of amino acid supplementation. For this purpose, C2C12 myotubes exposed to TNFa in the presence or in the absence of amino acid (glutamine or leucine) supplementation have been used. Myotube treatment with TNFa leads to both hyperexpression of the muscle-specific ubiquitin ligase atrogin-1, and enhanced activity of the Ca2?- dependent proteolytic system. These changes are associated with increased myostatin expression. Glutamine supplementation effectively prevents TNFa-induced muscle protein loss and restores normal myostatin levels. The results shown in the present study indicate a direct involvement of TNFa in the onset of myotube protein loss and in the perturbation of myostatin-dependent signaling. In addition, the protective effect exerted by glutamine suggests that amino acid supplementation could represent a possible strategy to improve muscle mass.

Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by Tumor Necrosis Factor-alpha

PENNA, FABIO;MINERO, Valerio Giacomo;COSTAMAGNA, DOMIZIANA;BONELLI, Gabriella;BACCINO, Francesco Maria;COSTELLI, Paola
2011

Abstract

Depletion of skeletal muscle protein mainly results from enhanced protein breakdown, caused by activation of proteolytic systems such as the Ca2?-dependent and the ATP-ubiquitin-dependent ones. In the last few years, enhanced expression and bioactivity of myostatin have been reported in several pathologies characterized by marked skeletal muscle depletion. More recently, high myostatin levels have been associated with glucocorticoidinduced hypercatabolism. The search for therapeutical strategies aimed at preventing/correcting protein hypercatabolism has been directed to inhibit humoral mediators known for their pro-catabolic action, such as TNFa. The present study has been aimed to investigate the involvement of TNFa in the regulation of both myostatin expression and intracellular protein catabolism, and the possibility to interfere with such modulations by means of amino acid supplementation. For this purpose, C2C12 myotubes exposed to TNFa in the presence or in the absence of amino acid (glutamine or leucine) supplementation have been used. Myotube treatment with TNFa leads to both hyperexpression of the muscle-specific ubiquitin ligase atrogin-1, and enhanced activity of the Ca2?- dependent proteolytic system. These changes are associated with increased myostatin expression. Glutamine supplementation effectively prevents TNFa-induced muscle protein loss and restores normal myostatin levels. The results shown in the present study indicate a direct involvement of TNFa in the onset of myotube protein loss and in the perturbation of myostatin-dependent signaling. In addition, the protective effect exerted by glutamine suggests that amino acid supplementation could represent a possible strategy to improve muscle mass.
40
585
594
A. Bonetto; F. Penna; V.G. Minero; P. Reffo; D. Costamagna; G. Bonelli; F.M. Baccino; P. Costelli
File in questo prodotto:
File Dimensione Formato  
Post-print-open-access-2014.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 554.26 kB
Formato Adobe PDF
554.26 kB Adobe PDF Visualizza/Apri
Amino-Acids-2011.pdf

Accesso riservato

Descrizione: articolo principale
Tipo di file: PDF EDITORIALE
Dimensione 658.58 kB
Formato Adobe PDF
658.58 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/130277
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 32
social impact